09:35 EST Capricor Therapeutics (CAPR) trading resumes
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAPR:
- Capricor Therapeutics trading halted, volatility trading pause
- Capricor Therapeutics Announces Positive Phase 3 Trial Results
- Capricor Therapeutics says Phase 3 HOPE-3 study met primary endpoint
- Capricor presents data on framework for loading oligonucleotides into exosomes
- Largest borrow rate increases among liquid names